Drug delivery

Tools & Techniques Drug delivery

First Contact

| Angus Stewart | 5 min read

An inside view on the San Diego company working to bring drug delivering contact lenses to market.

Research Field Pain & critical care

An Osteoarthritic Odyssey

Sitting Down With… Mike Clayman, CEO of Flexion Therapeutics, Inc., Burlington, Massachusetts, USA.

Tools & Techniques Drug delivery

Next Steps for the Self-Righting Insulin Pill

| Jonathan James

Will diabetes treatment be revolutionized by the drug delivery capsule inspired by the geometry of the leopard tortoise?

Tools & Techniques Drug delivery

Heavy Metal Wonder

| Jonathan James

An iridium-based photodynamic drug accumulates in cancer cell nuclei – and destroys them from within.

Tools & Techniques Cancer

Cytotoxic Remediation

| Jonathan James

How a 3D-printed chemical absorber could pave the way for higher chemotherapy doses – or lower risks.

Disease Area Infectious diseases

The Intersection of Infection and Biodefense

| Marcus Horwitz

Marcus Horwitz’s primary focus is on infectious diseases, but a number of pathogens he has studied led him into the realm of bio-terrorism.

Tools & Techniques Clinical trials

The Latest From the Cannabis Scientist

| Joanna Cummings

Talking at women in cannabis science, and meeting Raphael Mechoulam

Disease Area Drug delivery

The Next (Air)Wave of Inhalables

| David Lewis

For inhaler technology to evolve, questions about efficacy must be answered

Research Field Drug delivery

Recognizing Friend from Foe

| Werner Cautreels

Solutions are needed to teach the immune system to recognize biological drugs as partners, not plunderers.

Outside the Lab Drug delivery

The Cost of Treating Cancer

| Roisin McGuigan

When you crunch the numbers on drug development, are the costs of cancer drugs justified?

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register